Seeing Is Believing
Currently out of the existing stock ratings of Debanjana Chatterjee, 12 are a BUY (92.31%), 1 are a HOLD (7.69%).
Analyst Debanjana Chatterjee, currently employed at JONESTRADING, carries an average stock price target met ratio of 20% that have a potential upside of 37.52% achieved within 78 days.
Debanjana Chatterjee’s has documented 24 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TBPH, Theravance Biopharma at 29-Jun-2026.
Analyst best performing recommendations are on ABSI (ABSCI CORP).
The best stock recommendation documented was for ABSI (ABSCI CORP) at 11/28/2025. The price target of $9 was fulfilled within 208 days with a profit of $5.83 (183.91%) receiving and performance score of 8.84.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 22-Jan-2025
$11
$1.45 (15.18%)
$11
Buy Since 04-May-2023
$16
$5.11 (46.92%)
Buy Since 02-Oct-2024
$15
$4.11 (37.74%)
$10
Buy Since 04-Dec-2024
$9
$-1.89 (-17.36%)
$9
Buy Since 03-Jul-2024
$5.89
$-5 (-45.91%)
$6.4
Which stock is Debanjana Chatterjee is most bullish on?
Which stock is Debanjana Chatterjee is most reserved on?
What Year was the first public recommendation made by Debanjana Chatterjee?